I agree nothing is shoe in for sure. My fear is a CRL for part 2 or more likely part 3 CMC. In an HIV vacuum that would be a big hit to the PPS. But this company is so different. Cancer and Nash could play into pps before we ever potentially get a CRL. So I am going to let it ride until we know more about cancer and Nash. I should sell some now to take out the basis but I cannot do it. I trust that will not bite me in the ass. Knock on wood.

Seems like people play the PDUFA date on these biotechs. Sell after the run up. This one could be very different. Wow. Just the beginning.